Multiple myeloma patient advocate Jack Aiello has been living with myeloma for 28 years. In this conversation, he speaks with Dr. Shaji Kumar, a hematologist at the Mayo Clinic whose research focuses on the development of novel drugs for the treatment of myeloma.
They discuss the difference between smoldering myeloma and active myeloma, the determining factors of high-risk patients, and what high-risk smoldering patients can do to delay or possibly avoid progression to active myeloma.
Full story & transcript → [ Ссылка ]
To watch more patient stories and to help support our effort, subscribe to our channel at @ThePatientStory
Join Our Community:
Website : [ Ссылка ]
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
Contents of this Video:
00:00 - Intro
01:21 - What is smoldering multiple myeloma
07:26 - What is the difference between smoldering myeloma and multiple myeloma
09:36 - What is the Ascent trial?
13:41 - How long until SMM patients are cured?
15:04 - Are there still trials open for high risk smoldering patients?
16:56 - Asking your doctor about clinical trials (high risk smoldering patients)
#smolderingmultiplemyeloma #smm #multiplemyeloma #multiplemyelomaawareness #MMSM #thepatientstory #cancersurvivor #cancerstories #ASH22 #myelomatreatment #bloodcancer #cancer
